Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics - PubMed (original) (raw)
doi: 10.1080/15622975.2016.1181783. Epub 2016 Jul 12.
David Baldwin 2, Marianna Abelli 3, Carlo Altamura 4, Bernardo Dell'Osso 4, Katharina Domschke 5, Naomi A Fineberg 6, Edna Grünblatt 5 7 8 9, Marek Jarema 10, Eduard Maron 11 12 13, David Nutt 13, Stefano Pini 3, Matilde M Vaghi 14, Adam Wichniak 10, Gwyneth Zai 14 15 16 17, Peter Riederer 5 7 8
Affiliations
- PMID: 27403679
- DOI: 10.1080/15622975.2016.1181783
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics
Borwin Bandelow et al. World J Biol Psychiatry. 2016 Aug.
Abstract
Objectives: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD).
Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network.
Results: The present article (Part I) summarises findings on potential biomarkers in neuroimaging studies, including structural brain morphology, functional magnetic resonance imaging and techniques for measuring metabolic changes, including positron emission tomography and others. Furthermore, this review reports on the clinical and molecular genetic findings of family, twin, linkage, association and genome-wide association studies. Part II of the review focuses on neurochemistry, neurophysiology and neurocognition.
Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high-quality research has accumulated that will improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.
Keywords: Anxiety disorders; genetic; neurobiology; neuroimaging; obsessive–compulsive disorder; post-traumatic stress disorder; review.
Similar articles
- Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.
Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P. Bandelow B, et al. World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. World J Biol Psychiatry. 2017. PMID: 27419272 Free PMC article. Review. - Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTD.
Maron E, Lan CC, Nutt D. Maron E, et al. Curr Top Behav Neurosci. 2018;40:219-292. doi: 10.1007/7854_2018_49. Curr Top Behav Neurosci. 2018. PMID: 29796838 - Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder.
Freire RC, Cabrera-Abreu C, Milev R. Freire RC, et al. Adv Exp Med Biol. 2020;1191:331-346. doi: 10.1007/978-981-32-9705-0_18. Adv Exp Med Biol. 2020. PMID: 32002936 Review. - Posttraumatic obsessive-compulsive disorder: a case series.
Sasson Y, Dekel S, Nacasch N, Chopra M, Zinger Y, Amital D, Zohar J. Sasson Y, et al. Psychiatry Res. 2005 Jun 15;135(2):145-52. doi: 10.1016/j.psychres.2004.05.026. Psychiatry Res. 2005. PMID: 15922457 - Cognitive-behavioral therapy for anxiety disorders: why and how it works.
Basco MR, Glickman M, Weatherford P, Ryser N. Basco MR, et al. Bull Menninger Clin. 2000 Summer;64(3 Suppl A):A52-70. Bull Menninger Clin. 2000. PMID: 11002530
Cited by
- Impaired Non-Selective Response Inhibition in Obsessive-Compulsive Disorder.
Masharipov R, Korotkov A, Knyazeva I, Cherednichenko D, Kireev M. Masharipov R, et al. Int J Environ Res Public Health. 2023 Jan 9;20(2):1171. doi: 10.3390/ijerph20021171. Int J Environ Res Public Health. 2023. PMID: 36673927 Free PMC article. - Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety.
Wollmer MA, Makunts T, Krüger THC, Abagyan R. Wollmer MA, et al. Sci Rep. 2021 Dec 21;11(1):24173. doi: 10.1038/s41598-021-03713-x. Sci Rep. 2021. PMID: 34934096 Free PMC article. - Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study.
Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E. Ivanovs R, et al. BMC Public Health. 2018 Mar 6;18(1):328. doi: 10.1186/s12889-018-5238-7. BMC Public Health. 2018. PMID: 29510681 Free PMC article. - Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders.
Sharma R, Kumarasamy M, Parihar VK, Ravichandiran V, Kumar N. Sharma R, et al. CNS Neurol Disord Drug Targets. 2024;23(5):638-655. doi: 10.2174/1871527322666230412105711. CNS Neurol Disord Drug Targets. 2024. PMID: 37055898 Review. - ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders.
Bas-Hoogendam JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, Jahanshad N, Thomopoulos SI, Thompson PM, Veltman DJ, Winkler AM, Lueken U, Pine DS, van der Wee NJA, Stein DJ; ENIGMA-Anxiety Working Group. Bas-Hoogendam JM, et al. Hum Brain Mapp. 2022 Jan;43(1):83-112. doi: 10.1002/hbm.25100. Epub 2020 Jul 3. Hum Brain Mapp. 2022. PMID: 32618421 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical